US Stock MarketDetailed Quotes

LMAT LeMaitre Vascular

Watchlist
  • 98.650
  • +1.660+1.71%
Close Feb 14 16:00 ET
  • 98.650
  • 0.0000.00%
Post 16:35 ET
2.22BMarket Cap54.20P/E (TTM)

About LeMaitre Vascular Company

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Company Profile

SymbolLMAT
Company NameLeMaitre Vascular
Listing DateOct 19, 2006
Issue Price7.00
Founded1983
CEOMr. George W. Lemaitre
MarketNASDAQ
Employees630
Fiscal Year Ends12-31
Address63 Second Avenue
CityBurlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01803
Phone1-781-221-2266

Company Executives

  • Name
  • Position
  • Salary
  • George W. Lemaitre
  • Chairman of the Board and Chief Executive Officer
  • --
  • Joseph P. Pellegrino,Jr
  • Director, Chief Financial Officer, Secretary and Principal Accounting Officer
  • 1.07M
  • Ina Leininger
  • Regional Sales Manager, Southern Germany and Switzerland
  • --
  • Chance Kriesel
  • Area Sales Manager, West and Gulf Coast USA
  • --
  • Kimberly L. Cieslak
  • Vice President, Marketing
  • --
  • Jonathan W. Ngau
  • Vice President, Information Systems
  • --
  • Roli Kumar Choudhury
  • Vice President, Quality Affairs
  • --
  • Helen Goulding
  • Vice President, Sales, Northern Europe
  • --
  • Ryan H. Connelly
  • Senior Vice President, Advanced Manufacturing Engineering
  • --
  • Jacob Petersen
  • Senior Vice President, International
  • --
  • David Hissong
  • Vice President and General Counsel
  • --
  • Giovannella Deiure
  • Vice President, Sales, Southern Europe
  • --
  • Xiang Zhang
  • Vice President, Regulatory Affairs
  • --
  • Maik D. Helmers
  • Senior Vice President, Sales - Central Europe
  • --
  • Trent G. Kamke
  • Senior Vice President, Operations
  • 670.38K
  • Christopher D. Minnett
  • Vice President Sales and Marketing - Americas
  • --
  • Andrew Hodgkinson
  • Senior Vice President, Clinical, Regulatory and Quality Affairs
  • --
  • Stephane Maier
  • Senior Vice President, Operations - EMEA
  • --
  • James Russell
  • Vice President, Production and Supply Chain
  • --
  • David B. Roberts
  • Director and President
  • 1.13M
  • Jeanwon D. Park
  • Director, Sales - Northeast Asia
  • --
  • Daniel J. Mumford
  • Senior Director, Human Resources
  • --
  • Kathryn L. Tebbe
  • Senior Director, Financial Reporting
  • --
  • John J. O'Connor
  • Independent Director
  • 163.00K
  • Martha Shadan
  • Independent Director
  • 138.83K
  • Bridget A. Ross
  • Independent Director
  • 144.50K
  • John A. Roush
  • Independent Director
  • 146.50K
  • Lawrence J. Jasinski
  • Independent Director
  • 153.50K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.